Literature DB >> 16919925

Improved absorption of meloxicam via salt formation with ethanolamines.

Hyo-Kyung Han1, Hoo-Kyun Choi.   

Abstract

The present study aimed to investigate the effect of ethanolamine salt formation on the dissolution as well as in vivo pharmacokinetics of meloxicam. Three meloxicam-ethanolamine salts were prepared and their in vitro dissolution profiles were examined at pH 1.2 and 6.8. The pharmacokinetic profiles of meloxicam following an oral administration of meloxicam or its ethanolamine salts were also evaluated in rats. The dissolution rates of meloxicam and its ethanolamine salts were similarly slow at pH 1.2, however, at pH 6.8, ethanolamine salt formation significantly enhanced the dissolution rate of meloxicam. Meloxicam diethanolamine salt exhibited the highest dissolution rate at pH 6.8. The faster dissolution of meloxicam via ethanolamine salt formation at pH 6.8 appeared to be correlated well with more rapid absorption of meloxicam in rats. Tmax of meloxicam was significantly (p<0.05) shortened following an oral administration of ethanolamine salts. Furthermore, ethanolamine salts exhibited a trend toward the increase in AUC0-4 (initial exposure), while the overall exposure (AUC0-24) was similar between meloxicam and its salts. In conclusion, the ethanolamine salts of meloxicam, particularly diethanolamine salt of meloxicam, facilitated the rapid absorption of meloxicam while maintaining the prolonged exposure and may be used for the earlier onset of action for meloxicam.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16919925     DOI: 10.1016/j.ejpb.2006.07.003

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  10 in total

1.  Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam.

Authors:  Qikun Jiang; Jin Wang; Panqin Ma; Cuiru Liu; Mengchi Sun; Yinghua Sun; Zhonggui He
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

2.  Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress.

Authors:  Memy H Hassan; Mohamed M Ghobara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-31       Impact factor: 3.000

3.  Plasma Concentration of Meloxicam in Pediatric Rats.

Authors:  Kristina A Pugh; Kyle J Reitnauer; Robyn B Lee; William L Wilkins; John H McDonough; M Ross Pennington; Samantha R Litvin
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-11-01       Impact factor: 1.232

Review 4.  Research progress of cardioprotective agents for prevention of anthracycline cardiotoxicity.

Authors:  Jing Zhang; Xiaohai Cui; Yan Yan; Min Li; Ya Yang; Jiansheng Wang; Jia Zhang
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

5.  Development of meloxicam salts with improved dissolution and pharmacokinetic behaviors in rats with impaired gastric motility.

Authors:  Masanori Ochi; Ryo Inoue; Yukinori Yamauchi; Shizuo Yamada; Satomi Onoue
Journal:  Pharm Res       Date:  2012-09-15       Impact factor: 4.200

6.  Development and validation of a dissolution test for meloxicam and pridinol mesylate from combined tablet formulation.

Authors:  S E Vignaduzzo; P M Castellano; T S Kaufman
Journal:  Indian J Pharm Sci       Date:  2010-03       Impact factor: 0.975

7.  Characterization and In Vitro Skin Permeation of Meloxicam-Loaded Liposomes versus Transfersomes.

Authors:  Sureewan Duangjit; Praneet Opanasopit; Theerasak Rojanarata; Tanasait Ngawhirunpat
Journal:  J Drug Deliv       Date:  2010-11-07

Review 8.  Recent advances in improving oral drug bioavailability by cocrystals.

Authors:  Shahram Emami; Mohammadreza Siahi-Shadbad; Khosro Adibkia; Mohammad Barzegar-Jalali
Journal:  Bioimpacts       Date:  2018-05-31

9.  Multiparticulate Systems of Meloxicam for Colonic Administration in Cancer or Autoimmune Diseases.

Authors:  Eva Navarro-Ruíz; Covadonga Álvarez-Álvarez; M Ángeles Peña; Carlos Torrado-Salmerón; Zaid Dahma; Paloma Marina de la Torre-Iglesias
Journal:  Pharmaceutics       Date:  2022-07-20       Impact factor: 6.525

10.  Diclofenac Salts, VIII. Effect of the Counterions on the Permeation through Porcine Membrane from Aqueous Saturated Solutions.

Authors:  Adamo Fini; Glenda Bassini; Annamaria Monastero; Cristina Cavallari
Journal:  Pharmaceutics       Date:  2012-09-12       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.